Skip to main content

Table 2 Relationship between the expression of miR-198-5p and clinicopathological features in LUSC patients

From: Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR

Clinicopathological feature n miR-198-5p expression (2−ΔCq)
Mean ± SD t P
Tissue LUSC 23 4.3826 ± 1.7660 0.146 0.885
  Non-tumor 23 4.4522 ± 1.8263   
Gender Male 18 4.4670 ± 1.8711 0.425 0.675
  Female 5 4.0800 ± 1.4584   
Age < 60 15 4.0930 ± 1.4270 − 1.080 0.293
  ≥ 60 8 4.9250 ± 2.2833   
Smoking state No 12 4.3000 ± 1.2884 − 0.229 0.821
  Yes 11 4.4730 ± 2.2401   
Size ≤ 3 cm 7 4.2570 ± 2.1196 − 0.220 0.828
  > 3 cm 16 4.4380 ± 1.6633   
EGFR amplification No 17 4.7470 ± 1.8084 1.741 0.096
  Yes 6 3.3500 ± 1.2357   
Vascular invasion No 20 4.6100 ± 1.6914 1.656 0.113
  Yes 3 2.8670 ± 1.7786   
TNM stage I-II 10 5.4400 ± 1.5277 2.917 0.008
  III-IV 13 3.5690 ± 1.5228   
LNM No 11 4.8730 ± 2.0553 1.294 0.210
  Yes 12 3.9330 ± 1.3918   
EGFR protein Low 18 4.3280 ± 1.9013 − 0.277 0.785
  High 5 4.5800 ± 1.3142   
MET Low 13 4.9230 ± 1.6559 1.750 0.095
  High 10 3.6800 ± 1.7313   
Grading II 16 4.4130 ± 1.8326 0.12 0.906
  III 7 4.3140 ± 1.7411